Stream Biomedical, Inc., a privately held clinical-stage biopharmaceutical company, is dedicated to the development of first-in-class targeted therapeutics for the treatment of acute neurotrauma and chronic neurodegenerative diseases of high unmet need.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.